PREDICTION OF UNFAVORABLE OUTCOMES OF PREGNANCY BASED ON BIOCHEMICAL SCREENING IN TRIMESTER
Abstract
This article reviews the objectives of combination biochemical screening of unfavorable outcomes of pregnancy in trimester I. The characterization of prenatal screening markers is given, for example, β-hCG (beta-human chorionic gonadotropin) and РАРР-А (pregnancy-associated plasma protein A). The international and national approaches to the algorithm of carrying out of prenatal screening and conceptualization about prediction of pregnancy complications based on results of biochemical screening of serum concentrations of β-hCG and PAPP-A, are reviewed
About the Authors
I. O. Makarov
ФППОВ Первый МГМУ им. И.М. Сеченова Минздравсоцразвития России
Russian Federation
Russian Federation
E. V. Yudina
I.M. Sechenov Moscow State Medical University (MSMU), Moscow
Russian Federation
Russian Federation
E. I. Borovkova
I.M. Sechenov Moscow State Medical University (MSMU), Moscow
Russian Federation
Russian Federation
I. V. Martynova
I.M. Sechenov Moscow State Medical University (MSMU), Moscow
Russian Federation
Russian Federation
E. I. Kirpikova
I.M. Sechenov Moscow State Medical University (MSMU), Moscow
Russian Federation
Russian Federation
References
1. Белоусова В. Г. Комплексный клинико-биохимический скрининг в диагностике врожденной патологии у детей: дисс.... к.м.н.: Воронеж.-2004.-126 с
2. Горин В.С., Серов В.Н., Жабин С.Г. Ассоциированный с беременностью протеин А в диагностике синдрома Дауна и других нарушений перинатального периода//Акушерство и гинекология.-2000.-№ 2.-С. 3-5.
3. Заманская Т. А. Евсеева З. П. Евсеев А. В. Биохимический скрининг в I триместре при прогнозировании осложнений беременности//Российский вестник акушера-гинеколога.-М.2009.-№3.-С.14-18
4. Кащеева Т.К. Пренатальный биохимический скрининг -система, принципы, клинико-диагностические критерии, алгоритмы. Дисс.... д.б.н.: СПб.-2009.-245с
5. Кибардина Н.В. Современные возможности прогнозирования перинатальной заболеваемости: дисс. к.м.н.:Москва.-2009.-103 с.
6. Некрасова Е.С., Николаева Ю.А., Кащеева Т.К., Кузнецова Т.В., Баранов В.С. Внедрение алгоритма комбинированного скрининга хромосомной патологии плода в I триместре беременности. Опыт работы за 4 года.//Журнал акушерства и женских болезней.-2007.№1.-С.28-34
7. Некрасова Е.С. Комбинированный ультразуковой и биохимический скрининг хромосомной патологии в первом триместре беременности у беременных женщин северо-западного региона России. Автореф. дисс…. к.м.н.:СПб.-2005.-20с.
8. Солуянова Л.А. Акушерские аспекты биохимического скрининга беременных на альфа-фетопротеин и хорионический гонадотропин. Автореф. дисс. к.м.н.: Пермь.-2007.-25с.
9. Akolekar R, Etchegaray A, Zhou Y, Maiz N, Nicolaides KH.Maternal serum activin a at 11-13 weeks of gestation in hypertensive disorders of pregnancy. Fetal Diagn Ther. 2009;25(3):320-7.
10. Gagnon A, Wilson RD, Audibert F et al Obstetrical complications associated with abnormal maternal serum markers analytes. J Obstet Gynaecol Can. 2008 Oct;30(10):918-49.
11. Breathnach, FM, Malone, FD, Lambert-Messerlian, G, et al. First-and secondtrimester screening. Obstet Gynecol 2007; 110:651.
12. Deveci K, Sogut E, Evliyaoglu O.Pregnancyassociated plasma protein-A and C-reactive protein levels in pre-eclamptic and normotensive pregnant women at third trimester. J Obstet Gynaecol Res. 2009 Feb;35(1):94-8.
13. Goetzinger KR, Singla A, Gerkowicz S et al. The efficiency of first-trimester serum analytes and maternal characteristics in predicting fetal growth disorders. Am J Obstet Gynecol. 2009Oct;201(4):412.e1-6.
14. Kagan, KO, Wright, D, Spencer, K, et al. Firsttrimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 2008; 31:493.
15. Meloni P, D'Angeli I, Piazze J et al. First trimester PAPP-A levels associated with early prediction of pregnancy induced hypertension. Hypertens Pregnancy. 2009 Aug;28(4):361-8.
16. Poon LC, Stratieva V, Piras S, et al. Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11-13 weeks. Prenat Diagn. 2010 Mar;30(3):216-23.
Review
For citations:
Makarov I.O., Yudina E.V., Borovkova E.I., Martynova I.V., Kirpikova E.I. PREDICTION OF UNFAVORABLE OUTCOMES OF PREGNANCY BASED ON BIOCHEMICAL SCREENING IN TRIMESTER. Obstetrics, Gynecology and Reproduction. 2011;5(1):18-21. (In Russ.)
Views: 438
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
